Sponsored Content
Hi-Q Named Finalist at NutraIngredients Asia Awards 2023!
8 Sep 2023Hi-Q has been selected as a finalist at the prestigious NutraIngredients Asia Awards 2023!
Being shortlisted for the Nutrition Research Project Specialty Award highlights the potential impact of Hi-Q's research project. This recognition underscores the importance of further exploration and validation of OliFuco® Oligo Fucoidan as an therapeutic option for cancer cachexia, offering hope for countless individuals affected by this debilitating syndrome.
.png)
Founded in 1998, Hi-Q is a biotech company committed to "Nature Protection and Health Promotion".
Initially focusing on green aquaculture research, our R&D team discovered the vital role of brown seaweed in enhancing fish immune systems. Since 2007, we have been dedicated to researching and developing brown seaweed, resulting in the identification of our brown seaweed extract, OliFuco®, which exhibits unique bi-directional immunomodulation effects with significant benefits in cancer management.
Recognizing the challenges faced in cancer care, especially regarding nutrition resources, we aim to demonstrate the potential of OliFuco® as an adjunctive therapy for cancer patients experiencing cachexia and managing chronic diseases that contribute to cancer risk.
Our cancer-focused research project began in 2008. To date, we have published over 50 scientific papers, with over 30 of these papers directly focusing on its relationship to cancer and the immune system while others related to management of chronic diseases that contribute to cancer risk. These publications provide evidence of the efficacy of Fucoidan in various aspects, including immune modulation, prevention of tumour progression, improvement of chemotherapy and radiotherapy outcomes, improvement of side effects and cancer cachexia.
One significant milestone in our research journey occurred in 2017 when we successfully completed the first double-blind, randomized controlled trial at Kaohsiung Medical University. This landmark trial specifically evaluated the efficacy of OliFuco® as a supplemental therapy in metastatic colorectal cancer patients. The trial conclusively demonstrated the effectiveness of OliFuco® in enhancing the disease control rate among these patients. We are conducting ongoing studies.
Companies mentioned
Related categories
Related news
![Roquette at Fi Europe: Empowering people and planet via plant-based innovation [Interview]](/47/pdcnewsitem/12/35/84/th123584.png)
Roquette at Fi Europe: Empowering people and planet via plant-based innovation [Interview]
26 Jan 2024
Presenting its latest F&B solutions under the banner of ‘Empowering healthier and more sustainable food choices’, Roquette’s appearance at the most recent edition of Fi Europe coincided with the innovative company’s 90th anniversary.
Read more![Emsland at Fi Europe 2023: Leading the field in sustainability and future-proofed food [Interview]](/47/pdcnewsitem/12/35/83/th123583.png)
Emsland at Fi Europe 2023: Leading the field in sustainability and future-proofed food [Interview]
26 Jan 2024
Germany-headquartered Emsland is a vegetable protein and fibre pioneer responding in earnest to the food sector’s sustainability challenge, while supporting its customers to develop plant-based, clean label and nutritionally enhanced products through “...
Read more
Stand out from the shelf and put Health First with Prebiotic Chicory Root Fibres
22 Jan 2024
If you are looking to differentiate from all other products on the market, then innovating with proven prebiotics should be your next New Product Development. When it comes to food and drink choices, consumers often take into consideration a manif...
Read more
SYNBALANCE ANNOUNCES ITS FIRST CAPSULE COLLECTION FOR INCLUSING HEALTH
20 Dec 2023
SynBalance, the biotics-oriented company, focused on delivering highly scientifically evidenced probiotic solutions, is proud to present THE ART OF WELL-BEING capsule collection.
Read more
Bioriginal expands the business in The Netherlands and Japan
13 Dec 2023
Bioriginal Food & Science Corp has completed two significant acquisitions that will expand the company’s global footprint in the EU and Asia.
Read more
Bioriginal expands in Germany acquiring plant-based oil products company
13 Dec 2023
Bioriginal has expanded into Germany with the acquisition of Pflanzenölmühle Kroppenstedt GmbH operating as Kroppenstedter Ölmühle, a century-old, family-owned mill that specializes in the pressing of plant-based oil products from c...
Read more
Bioriginal Acquires Softgel Co. To Expand Nutrition Products
13 Dec 2023
Bioriginal has expanded further into the United States with the acquisition of all the operating assets of Softgel Co. ("Softgel"), including a state-of-the-art softgel, squeeze tube and tincture manufacturing facility that specializes in enc...
Read more
ACT Expands Global Presence: New Sales Office in Spain in Febuary 2024
13 Dec 2023
ACT proudly announces the inauguration of a new sales office in Spain as of 1st of February 2024. This strategic expansion marks a significant milestone in the company's global growth initiative, aiming to strengthen its foothold in the European ma...
Read more
Bunge’s Beleaf™ PlantBetter: Elevating Plant-Based Alternatives to Match Dairy Butter - A breakthrough for taste, texture, and versatility on par with dairy butter
12 Dec 2023
Zaandam, The Netherlands, 20 November 2023 – Bunge, a global leader in food and agribusiness, introduces Beleaf™ PlantBetter, a ground-breaking plant-based alternative crafted to satisfy the growing demand for superior-tasting and environme...
Read more
ofi's Carbon Scenario Planner wins prestigious Food Ingredients Europe Award
12 Dec 2023
ofi’s Carbon Scenario Planner (CSP), a new digital tool developed to help food and beverage manufacturers model the impact of different scenarios for reducing greenhouse gas emissions has won the 2023 Sustainability Innovation Award at Food Ingre...
Read more